Clinical Trials Browser

Phase NA × Nasopharyngeal Carcinoma × 1 year × Clear all

NCT07578727 2026-05-15

A Multicenter, Prospective, Phase III Clinical Study of Proton Intensity-modulated Radiotherapy Versus Photon Intensity-modulated Radiotherapy for Untreated Non-metastatic Nasopharyngeal Carcinoma

Phase NA Not yet recruiting

Nasopharyngeal Carcinoma

NCT04425265 2026-05-08

Plasma Radiofrequency Ablation at Low Temperature Versus Electrocautery Block Resection at High Frequency for Localized Recurrent Nasopharyngeal Carcinoma

Phase NA Recruiting

Nasopharyngeal Carcinoma

NCT06682442 2026-05-01

Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma

Phase NA Recruiting

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms, Epstein-Barr Virus Infections

NCT05531916 2026-04-30

CIPN

Phase NA Active not recruiting

Nasopharyngeal Carcinoma

NCT07552883 2026-04-27

EPoRN

Phase NA Not yet recruiting

Nasopharyngeal Carcinoma, Necrosis, Radiation Injuries

NCT06662058 2026-04-23

Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation

Phase NA Recruiting

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT07412314 2026-03-09

Proton Therapy for Recurrent Nasopharyngeal Carcinoma

Phase NA Recruiting

Nasopharyngeal Carcinoma

NCT05389306 2026-03-03

NPC-LN

Phase NA Completed

Nasopharyngeal Carcinoma, Disease

NCT01365169 2026-01-07

Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"

Phase NA Recruiting

GastrointestinalHead & Neck

Nasopharyngeal Carcinoma, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Neoplasm Metastasis, Neoplasms, Oropharyngeal Neoplasms, Somatostatinoma, Colorectal Neoplasms

NCT07248696 2025-11-25

Tislelizumab Plus Chemotherapy With Response-Adapted Radiotherapy for de Novo Metastatic Nasopharyngeal Carcinoma: A Prospective, Phase II Trial

Phase NA Active not recruiting

Nasopharyngeal Carcinoma

NCT07019870 2025-06-13

Screening for Early Diagnosis of Nose Cancer

Phase NA Recruiting

20,000 enrolled

Nasopharyngeal Carcinoma

NCT04823468 2025-06-10

Effect of Oral Nutritional Supplements on Body Weight Loss of Patients With Nasopharyngeal Carcinoma

Phase NA Completed

Nasopharyngeal Carcinoma, Body Weight